WESTMINSTER, Colo., June 25, 2014 – Neuromonics, Inc., manufacturer and distributor of clinically proven tinnitus treatment devices, has signed a reseller agreement with AuDConnex.
AuDConnex will obtain special pricing, marketing and other support on all Neuromonics products for its members, according to Eula Adams, CEO of Neuromonics. The AudConnex buying group provides competitive pricing on audiology products to members, as well as training and education on practice management and advances in technology that impact the audiology industry.
“Agreements such as the one with AuDConnex allow more audiologists and hearing aid providers – and more consumers – to hear the good news about tinnitus relief,” says Adams. “AudConnex will serve as an essential partner to Neuromonics, delivering the miracle of tinnitus relief to more tinnitus sufferers.”
Neuromonics manufactures and distributes clinically proven, FDA-cleared medical devices to treat tinnitus, the condition often described as buzzing, ringing, hissing, humming, roaring, whistling or “ringing in the ears” that someone hears in the absence of any external sound. Globally, tinnitus affects an estimated 10-15 percent of the population. In the United States alone, more than 50 million people suffer from the condition, according to the American Tinnitus Association. Usually brought on by exposure to loud noise, tinnitus is especially significant in the military, with more than 34 percent of returning veterans from Iraq and Afghanistan suffering from the condition.
Neuromonics products use calming, relaxing music embedded with a neural stimulus that interacts with the tinnitus perception, explains Adams. The music engages the auditory pathways to promote neural plastic changes. Over time, these changes help the brain to filter out the tinnitus perception, reducing tinnitus disturbance and providing long-term relief from symptoms. The compact devices are simple to use, function much like familiar consumer music players, and fit easily into patients’ lifestyles.
Neuromonics, Inc. (www.neuromonics.com)
Based in Westminster, Colo., Neuromonics, Inc., manufactures and distributes clinically proven, FDA-cleared medical devices to treat tinnitus. The patented and clinically proven Oasis, working the Neuromonics Tinnitus Treatment, provides long-term treatment and significant relief for those with severe tinnitus. The Haven, with the ability to program and individualize hearing profiles, is a management tool offering situational relief for tinnitus symptoms. The Sanctuary, also a management tool, works with pre-programmed profiles for on-demand relief.
With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus. Today, Neuromonics provides its devices to nearly 2,000 hearing professionals on four continents, through direct relationships and reseller partners. Neuromonics news includes segments on national media including “The Doctors” and CNN.